PaxGenBio Co., Ltd. (Bio-company of Peaceful Gene), was established in 2015 as a molecular diagnostics company that develops, manufactures and markets a portfolio of IVD products targeting infectious diseases and cancers. PaxGenBio applies its proprietary, chimeric technologies that combine techniques for molecular and immune diagnostics. One of its original technologies, MPCR-ULFA that combines multiplex PCR amplification and universal lateral flow assay (ULFA) enables sensitive, specific, fast, affordable and easy nucleic acid tests that are especially appropriate for applications in low resource settings.

Dr. Park Young-Suk, who is currently serve as CEO at PaxGenBio established the company in the basis of his deeply focused career in in vitro diagnostics field. He is a molecular diagnostic specialist who has endeavored over 25 years to research and commercialize molecular diagnostics. Dr. Park served as director of the department of molecular diagnosis and human genome at Seoul Medical Science Institute, director of the diagnostic research institute at LG Life Sciences Ltd, head of the Bioneer Corp.'s diagnosis division, and he also served as director of the GreenCross Medical Science’ research center.

PaxGenBio pursues a world where more people live healthy lives in peace. All members are striving for the mission by developing and providing more accurate and affordable molecular diagnostic kits to more people.

PaxGenBio, will make best effort to listen to the opinions and valuable advice of our customers and shareholders to make better improvements for further progress and successes.
We sincerely ask for your interest and support.

Thank you very much.

4 Mar. 2019
Young Suk Park, CEO